ARCHIVES

Abstracts Deadline For Cancer Congress Extended To Dec. 31

This article is from The Cancer Letter archive.

Vol. 11 No. 48 | December 13, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

April 30, 2010

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002